Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis

CS Eberhardt, G Blanchard-Rohner… - Clinical Infectious …, 2016 - academic.oup.com
Background. Maternal immunization against pertussis is currently recommended after the
26th gestational week (GW). Data on the optimal timing of maternal immunization are …

Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series

P Vetter, CS Eberhardt, B Meyer, PA Martinez Murillo… - MSphere, 2020 - Am Soc Microbiol
Viral shedding patterns and their correlations with immune responses are still poorly characterized
in mild coronavirus (CoV) disease 2019 (COVID-19). We monitored shedding of viral …

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

M Cornberg, M Buti, CS Eberhardt, PA Grossi… - Journal of …, 2021 - Elsevier
… 1 2 3 , Maria Buti 4 , Christiane S. Eberhardt 5 , Paolo Antonio Grossi 6 7 , Daniel Shouval
8 … protection, the requirement for booster vaccination(s) and the level of protection against …

Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer

CS Eberhardt, HT Kissick, MR Patel, MA Cardenas… - Nature, 2021 - nature.com
T cells are important in tumour immunity but a better understanding is needed of the
differentiation of antigen-specific T cells in human cancer 1 , 2 . Here we studied CD8 T cells in …

Defining HPV-specific B cell responses in patients with head and neck cancer

A Wieland, MR Patel, MA Cardenas, CS Eberhardt… - Nature, 2021 - nature.com
Tumours often contain B cells and plasma cells but the antigen specificity of these
intratumoral B cells is not well understood 1 , 2 , 3 , 4 , 5 , 6 , 7 – 8 . Here we show that human …

[HTML][HTML] Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

M Bekliz, K Adea, P Vetter, CS Eberhardt… - Nature …, 2022 - nature.com
Emerging SARS-CoV-2 variants raise questions about escape from previous immunity. As
the population immunity to SARS-CoV-2 has become more complex due to prior infections …

[HTML][HTML] Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity

D Yahav, D Yelin, I Eckerle, CS Eberhardt… - Clinical Microbiology …, 2021 - Elsevier
By the beginning of November 2020, almost 50 million cases of coronavirus disease 2019 (COVID-19)
had been reported worldwide, with over 35 million people defined as recovering …

Robust T-cell responses in anti-CD20-treated patients following COVID-19 vaccination: a prospective cohort study

…, AM Didierlaurent, CS Eberhardt - Clinical Infectious …, 2022 - academic.oup.com
Background Patients treated with anti-CD20 therapy are particularly at risk of developing
severe coronavirus disease 2019 (COVID-19); however, little is known regarding COVID-19 …

[HTML][HTML] Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study

…, S Baggio, A Didierlaurent, CS Eberhardt… - Clinical Microbiology …, 2021 - Elsevier
Objectives To evaluate longitudinally the persistence of humoral immunity for up to 6 months
in a cohort of hospital employees with mild coronavirus disease 2019 (COVID-19). Methods …

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper

T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …